MX340672B - Procedimiento para la obtencion de acidos grasos de interes farmacologico y nutricional. - Google Patents

Procedimiento para la obtencion de acidos grasos de interes farmacologico y nutricional.

Info

Publication number
MX340672B
MX340672B MX2012015207A MX2012015207A MX340672B MX 340672 B MX340672 B MX 340672B MX 2012015207 A MX2012015207 A MX 2012015207A MX 2012015207 A MX2012015207 A MX 2012015207A MX 340672 B MX340672 B MX 340672B
Authority
MX
Mexico
Prior art keywords
obtainment
pharmacological
procedure
fatty acids
compound
Prior art date
Application number
MX2012015207A
Other languages
English (en)
Other versions
MX2012015207A (es
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MX2012015207A publication Critical patent/MX2012015207A/es
Publication of MX340672B publication Critical patent/MX340672B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432—Eicosapentaenoic acids [EPA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434—Docosahexenoic acids [DHA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)

Abstract

La presente invención se refiere a un procedimiento para la obtención de ácidos grasos de interés farmacológico y nutricional que comprende las etapas de alimentación de un gas que comprende CO2 a un reactor que contiene un cultivo que comprende al menos una especie de microalga capaz de realizar la fotosíntesis, realización del proceso de la fotosíntesis por la especie de microalga a partir del CO2 alimentado, produciendo una biomasa que contiene un compuesto de fórmula general (I): (Ver Formula) extracción del compuesto de fórmula general (I) de la biomasa, y concentración y/o purificación de dicho compuesto.
MX2012015207A 2010-06-23 2010-06-23 Procedimiento para la obtencion de acidos grasos de interes farmacologico y nutricional. MX340672B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2010/070424 WO2011161274A1 (es) 2010-06-23 2010-06-23 Procedimiento para la obtención de ácidos grasos de interés farmacológico y nutricional

Publications (2)

Publication Number Publication Date
MX2012015207A MX2012015207A (es) 2013-05-20
MX340672B true MX340672B (es) 2016-07-20

Family

ID=43902548

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012015207A MX340672B (es) 2010-06-23 2010-06-23 Procedimiento para la obtencion de acidos grasos de interes farmacologico y nutricional.

Country Status (20)

Country Link
US (1) US9573875B2 (es)
EP (1) EP2586869B1 (es)
JP (1) JP5934704B2 (es)
CN (1) CN103038355B (es)
AU (1) AU2010355794B2 (es)
BR (1) BR112012033087A2 (es)
CA (1) CA2803264A1 (es)
CY (1) CY1118701T1 (es)
DK (1) DK2586869T3 (es)
ES (1) ES2613580T3 (es)
HR (1) HRP20170252T1 (es)
HU (1) HUE031914T2 (es)
LT (1) LT2586869T (es)
MX (1) MX340672B (es)
NZ (1) NZ606131A (es)
PL (1) PL2586869T3 (es)
PT (1) PT2586869T (es)
SI (1) SI2586869T1 (es)
WO (1) WO2011161274A1 (es)
ZA (1) ZA201300632B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464416B1 (es) 2012-10-30 2015-03-31 Biosinkco2 Tech Lda Proceso para la producción de biomasa y productos derivados de ella mediante cultivo de algas unicelulares en medio acuoso alimentado con una corriente de CO2, y planta diseñada para tal fin
KR101693549B1 (ko) * 2014-07-10 2017-01-06 순천대학교 산학협력단 테트라셀미스 수에시카 분획물을 포함하는 비만의 예방 또는 치료용 조성물
EP3273954B1 (en) 2015-03-26 2020-10-28 Tiberio Bruzzese Purified compositions of polyunsaturated fatty acids, their preparation method and their use
KR101693548B1 (ko) * 2016-03-21 2017-01-06 순천대학교 산학협력단 테트라셀미스 수에시카 분획물을 포함하는 당뇨병의 예방 또는 치료용 조성물
CN109022508B (zh) * 2018-08-24 2021-03-19 暨南大学 一种利用真眼点藻纲微藻生产棕榈油酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
JP3509902B2 (ja) * 1993-08-17 2004-03-22 財団法人地球環境産業技術研究機構 新規微細藻類及びそれを用いて高濃度二酸化炭素を固定する方法
WO2008134836A2 (en) * 2007-05-02 2008-11-13 Ouro Fino Participações E Empreendimentos S.A. Process to produce biodiesel and/or fuel oil
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
EP2135939A1 (en) * 2008-06-20 2009-12-23 Stroïazzo-Mougin, Bernard A. J. Process for obtaining a high nutritional value product and/or for transforming it into energy resources

Also Published As

Publication number Publication date
PT2586869T (pt) 2017-02-22
RU2013102897A (ru) 2014-07-27
WO2011161274A1 (es) 2011-12-29
BR112012033087A2 (pt) 2019-09-24
PL2586869T3 (pl) 2017-05-31
CA2803264A1 (en) 2011-12-29
HRP20170252T1 (hr) 2017-04-07
JP2013535957A (ja) 2013-09-19
HUE031914T2 (en) 2017-08-28
JP5934704B2 (ja) 2016-06-15
AU2010355794A1 (en) 2013-02-07
NZ606131A (en) 2015-02-27
CN103038355B (zh) 2015-05-20
CN103038355A (zh) 2013-04-10
DK2586869T3 (en) 2017-02-20
MX2012015207A (es) 2013-05-20
CY1118701T1 (el) 2017-07-12
LT2586869T (lt) 2017-03-10
EP2586869A1 (en) 2013-05-01
ES2613580T3 (es) 2017-05-24
EP2586869B1 (en) 2016-11-16
US20130197086A1 (en) 2013-08-01
ZA201300632B (en) 2013-09-25
US9573875B2 (en) 2017-02-21
SI2586869T1 (sl) 2017-04-26
AU2010355794B2 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
MX356002B (es) Método y sistema para el procesamiento de especies acuáticas.
WO2013082574A3 (en) Microbial-based process for high-quality protein concentrate
WO2010115201A3 (en) Reactor system and method for processing a process fluid
MX351511B (es) Composiciones,articulos, aparatos, metodos y sistemas relativos a biomasa de algas.
EA201171318A1 (ru) Улучшение улавливания углерода при ферментации
MX2012008939A (es) Proceso para producir etanol y una corriente de alimentacion de ester para la produccion de ester.
SG195118A1 (en) Process for the production of estetrol intermediates
EA201390593A1 (ru) Способ и система для производства спиртов и/или кислот
MY172658A (en) Process for preparing methylmercaptopropionaldehyde
MX340672B (es) Procedimiento para la obtencion de acidos grasos de interes farmacologico y nutricional.
MX348547B (es) Nuevo proceso para cultivar bacterias para el mejoramiento del rendimiento de las poliosas capsulares.
MX2014005870A (es) Proceso para preparar compuestos de 1h -pirazol - 5 - carboxilato n - sustituidos y derivados de los mismos.
UY33325A (es) Purificación mediante adsorción de colorante caramelo
MX2011006293A (es) Procedimiento para la fabricacion de acetato de vinilo.
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
MX2014004688A (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.
MX2014004083A (es) Metodo para aislar ingenol.
EA201300646A1 (ru) Способ получения небиволола
TN2009000516A1 (en) Protein production in plants
MX2012007447A (es) Proceso de epoxidacion y microestructura.
MY182164A (en) Process for producing acetic acid by introducing a lithium compound
MX2011008810A (es) Metodo para fabricar un producto de fermentacion que contiene propionato y acetato que comprende un paso de eliminacion de compuestos relacionados con carbonato.
EA201890299A1 (ru) Способ получения алкилового эфира низшей жирной кислоты
CU20130161A7 (es) Método de fermentación de abe que comprende assorción de producto a través de isoforina
MX2012013388A (es) Metodo para fabricar 1-alquil-3-difluorometil-5-hidroxipirazoles.

Legal Events

Date Code Title Description
FG Grant or registration